University of Alberta
Edmonton, Alberta, T6G 1C9, Canada
Location status: Recruiting
NCT Number: NCT05579678
People who undergo allogeneic bone marrow transplant for blood cancers receive the highest chemotherapy doses possible that humans can receive and still survive. As a result, they have devastating side effects during the procedure and for many years afterwards. Damage to organs and muscles cause long-lasting physical weakness and the psychological experience is severe enough to be termed 'post traumatic stress disorder' that also lasts for many years. These effects are worsened by the fact that most Canadians live several hours away from treatment and transplant centers, leaving them entirely on their own to manage these difficult long term effects. The APOLLO team will perform a qualitative study to learn the experiences of people undergoing allogeneic bone marrow transplant while they receive access to a supportive care computer 'app' and telephone support from nursing, exercise and nutrition experts. In this way, the APOLLO team will learn the most helpful type and timing of supportive care from those who know best.
Interested in participating?
Request Info18 year–70 year
All sexes
Observational
Edmonton, Alberta, T6G 1C9, Canada
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supportive nursing, nutritional and physical activity with a handheld 'app'
Time frame: 1 year
Description: Questionnaire to assess usefulness of a multimodal supportive care App that includes care navigation (nursing, exercise, nutrition)
Contact information is provided by the study sponsor or research team.
University of Alberta
Other
Acronym: APOLLO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07157514
Acute Leukemia, Acute Myelogenous Leukemia
View Trial DetailsNCT05855707
Allogeneic Disease, GVHD,Acute
View Trial DetailsNCT04966156
Allogeneic Disease, Cancer Rehabilitation
Toronto, Ontario, Canada
View Trial DetailsNCT03343834
Allogeneic Disease, Epstein-Barr Viraemia
Paris, France
View Trial Details